Figure 3
Survival of CN-AML patients according to ELN genetic group and LEF1 expression. (A) RFS and (B) OS of CN-AML patients in the ELN favorable genetic group. (C) RFS and (D) OS of CN-AML patients in the ELN intermediate-I genetic group.
Survival of CN-AML patients according to ELN genetic group and LEF1 expression. (A) RFS and (B) OS of CN-AML patients in the ELN favorable genetic group. (C) RFS and (D) OS of CN-AML patients in the ELN intermediate-I genetic group.
